RIPK2 is an unfavorable prognosis marker and a potential therapeutic target in human kidney renal clear cell carcinoma

Receptor Interacting Serine/Threonine Kinase 2 (RIPK2) is located on chromosome 8q21 and encodes a protein containing a C-terminal caspase activation and recruitment domain (CARD), which is a component of signaling complexes in both the innate and adaptive immune pathways. To estimate the value of R...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Diangeng, Tang, Liangyou, Liu, Bo, Xu, Shibo, Jin, Meiling, Bo, Wu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064209/
https://www.ncbi.nlm.nih.gov/pubmed/33790054
http://dx.doi.org/10.18632/aging.202808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064209/
https://www.ncbi.nlm.nih.gov/pubmed/33790054
http://dx.doi.org/10.18632/aging.202808

Ejemplares similares